MGRO πŸ“ˆ MustGrow Biologics - Overview

Exchange: V • Country: Canada • Currency: CAD • Type: Common Stock •

MGRO: Biopesticides, Biofertilizers, Soil Amendments, Biocontrols

MustGrow Biologics Corp., an agricultural biotechnology company, focuses on development and commercialization of natural biological technologies and products from mustard seeds. It provides Biocontrol technology platform to treat soil-borne diseases and pests for various crops, including fruit, vegetables, and others; treat unwanted plant growth for use in organic agriculture, and home and garden markets, as well as agriculture markets where glyphosate has been banned; and suppress sprouting, and treat disease and pathogen for storage and food preservation markets. The company also offers TerraMG, a mustard-derived soil biopesticide technology. In addition, it is developing TerraSante, an organic soil amendment and biofertility technology. The company was formerly known as Duport Capital Ltd. and changed its name to MustGrow Biologics Corp. in March 2018. MustGrow Biologics Corp. was incorporated in 2014 and is headquartered in Saskatoon, Canada. Web URL: https://mustgrow.ca

Additional Sources for MGRO Stock

Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle

MGRO Stock Overview

Market Cap in USD 54m
Sector Basic Materials
Industry Agricultural Inputs
GiC Sub-Industry Fertilizers & Agricultural Chemicals
IPO / Inception

MGRO Stock Ratings

Growth 5y 35.4%
Fundamental -23.0%
Dividend -
Rel. Strength Industry -2220
Analysts -
Fair Price Momentum 1.14 CAD
Fair Price DCF 0.86 CAD

MGRO Dividends

No Dividends Paid

MGRO Growth Ratios

Growth Correlation 3m 29.6%
Growth Correlation 12m 3.6%
Growth Correlation 5y 17.9%
CAGR 5y 17.27%
CAGR/Mean DD 5y 0.36
Sharpe Ratio 12m 0.22
Alpha -25.02
Beta 0.67
Volatility 82.45%
Current Volume 10.9k
Average Volume 20d 14.5k
What is the price of MGRO stocks?
As of December 22, 2024, the stock is trading at CAD 1.22 with a total of 10,910 shares traded.
Over the past week, the price has changed by -16.55%, over one month by -35.29%, over three months by +15.24% and over the past year by -3.20%.
Is MustGrow Biologics a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, MustGrow Biologics is currently (December 2024) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of -22.96 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of MGRO as of December 2024 is 1.14. This means that MGRO is currently overvalued and has a potential downside of -6.56%.
Is MGRO a buy, sell or hold?
MustGrow Biologics has no consensus analysts rating.
What are the forecast for MGRO stock price target?
According to ValueRays Forecast Model, MGRO MustGrow Biologics will be worth about 1.3 in December 2025. The stock is currently trading at 1.22. This means that the stock has a potential upside of +2.46%.
Issuer Forecast Upside
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 1.3 2.5%